INTU heads into tomorrow's fiscal Q4 results with shorts unwinding sharply, the stock up 20% over the past month, and analysts cutting targets even as they hold positive ratings — a setup that tells two different stories depending on which signal you trust.
The clearest development in positioning is the short side retreat. Short interest has fallen nearly 20% over the past week to 4.3% of free float, after holding stubbornly above 15 million shares through most of July and into early August. The unwind started abruptly around August 11 — the same period the stock began accelerating — and the pace of covering has been unusually sharp for a name this size. Borrow conditions confirm there is no squeeze mechanics driving this: cost to borrow is negligible at 0.48%, and availability is extraordinarily loose at over 8,000% of short interest, meaning the lending pool is essentially unlimited. Shorts are covering by choice, not by force. The ORTEX short score has dropped from near 40 to 35.8 over the same stretch, tracking the de-risking. Options are mildly more defensive than usual — the put/call ratio is running at 0.88, roughly one standard deviation above its 20-day average — but that is a measured hedge rather than panic buying. Positioning overall looks cautious rather than crowded on either side.
The analyst picture is where the real tension sits. This week Deutsche Bank's Brad Zelnick cut his target from $530 to $425 while keeping a Buy rating — a meaningful reduction from a bellwether firm filed just hours before the print. That follows a similar pattern from Mizuho, which trimmed to $430 from $500 on Monday, and Citigroup, which cut to $457 from $591 last week, both maintaining positive ratings. The message from the bull camp is consistent: the business is sound but near-term growth assumptions have been too high. The bear camp is less forgiving. Piper Sandler's Underweight rating with a $250 target implies the stock is still materially overvalued even after its YTD collapse. Morgan Stanley's late-July downgrade to Equal-Weight with a $335 target essentially argued the stock was near fair value at levels now 5% below where it trades today. The consensus mean target is $449 — implying roughly 28% upside from the current $350 close — but that figure is being actively dragged lower with each revision cycle. On valuation, the EV/EBITDA multiple has eased about 1.2 turns over the past 30 days, a modest re-rating that trails the pace of target-price cuts. EPS momentum scores remain strong — ranking in the 90th percentile on 30-day momentum and the 83rd on 90-day — which is the most concrete data point bulls can point to heading into tomorrow's release.
The earnings history deserves attention given the magnitude of tomorrow's event. The last two quarterly prints produced severe single-day declines: the May report sent the stock down 23% in one session, with losses extending to match over the following week. The print before that fell 17% on the day. These are not small moves for a large-cap software name. The stock has recovered 20% in the past month on what appears to be pre-earnings repositioning and short covering, which means some of the technical support from an oversold bounce may already be exhausted going into the release. Close peers paint a mixed backdrop: HUBS gained 5% on the day and GWRE added 3.4%, while NOW lost over 6% for the week — illustrating the bifurcated sentiment running through enterprise software right now.
The August 20 print is therefore less about whether Intuit's franchise is intact and more about whether management's forward guidance can arrest a months-long pattern of estimate compression that has driven targets from the $500s to the $400s in a single quarter.
See the live data behind this article on ORTEX.
Open INTU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
